The Chief Executive Officer of Lucid Diagnostics Inc. is Dr. Lishan Aklog, who has successfully directed the commercial-stage cancer prevention medical diagnostics enterprise. A trained cardiothoracic surgeon, medical innovator, and seasoned biotechnology entrepreneur, he also serves as the Chairman and CEO of PAVmed Inc., Lucid's parent organization. Under his strategic executive leadership, the company focuses heavily on advancing commercial adoption, expanding clinical laboratory operations, and driving widespread insurance reimbursement coverage for its proprietary EsoGuard esophageal DNA test designed to prevent esophageal cancer deaths through early detection.